AMAG Pharmaceuticals, Inc. to Participate in the Barclays High Yield Bond and Syndicated Loan Conference

WALTHAM, Mass., June 5, 2015 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that Frank Thomas, AMAG’s president and chief operating officer, will present at the Barclays High Yield Bond and Syndicated Loan Conference on Thursday, June 11, 2015 at 1:25 p.m. MDT in Colorado. The session will include a company presentation followed by a question and answer session, in which the company’s financial results, business update, regulatory matters, and growth prospects will be discussed.

A live audio webcast of the discussions will be accessible through the Investors section of the company’s website at Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 30 days.

About AMAG

AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG is to bring to market therapies that provide clear benefits and improve patients’ lives. In addition to continuing to pursue opportunities to make new advancements in patients’ health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies. For additional company information, please visit

CONTACT: AMAG Pharmaceuticals, Inc. Contact:
         Linda Lennox
         Vice President, Investor Relations & Corporate Communications

AMAG Pharmaceuticals logo

AMAG Pharmaceuticals, Inc.